Evolution of treatment targets in Crohn's disease

被引：4
|
作者：
White, Jonathan R. [1 ,2 ,3 ]
Jairath, Vipul [4 ,5 ]
Moran, Gordon W. [1 ,2 ,3 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England
[2] Univ Nottingham, Nottingham, England
[3] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England
[4] Western Univ, Div Gastroenterol, Dept Med, London, ON, Canada
[5] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
来源：
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2019年 / 38-39卷
关键词：
Crohn's disease; Treatment targets; Patient reported outcomes; Clinician reported activity indices; Biomarkers; Endoscopy; Imaging; Histology; INFLAMMATORY-BOWEL-DISEASE; PATIENT-REPORTED OUTCOMES; C-REACTIVE PROTEIN; POST-HOC ANALYSIS; QUALITY-OF-LIFE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; ACTIVITY INDEX; LEMANN INDEX; MAINTENANCE THERAPY;
D O I：
10.1016/j.bpg.2019.02.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Crohn's disease is a chronic relapsing and remitting inflammatory disorder of the gastrointestinal tract, associated with significantly morbidity due to both symptoms and complications that have a considerable detrimental impact on a patient's quality of life. An early treat to target approach with disease modifying agents has been shown to significantly improve long term outcomes, demonstrated by a number of therapeutic targets in a number of modalities. This review will outline the current treatment targets and measures of disease burden in Crohn's disease. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] Treatment of postoperative Crohn's disease
    Froehlich, F
    Juillerat, P
    Felley, C
    Mottet, C
    Vader, JP
    Burnand, B
    Michetti, P
    Gonvers, JJ
    DIGESTION, 2005, 71 (01) : 49 - 53
  • [32] Crohn's disease - diagnosis and treatment
    Hebzda, Andrzej
    Szczeblowska, Dorota
    Serwin, Dariusz
    Wojtun, Stanislaw
    Hebzda, Zbigniew
    Grys, Iwon
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2011, 7 (02): : 98 - 103
  • [33] Treatment of Crohn's disease: The "long" of it
    Hanauer, SB
    Thisted, RA
    GASTROENTEROLOGY, 2005, 128 (07) : 2164 - 2166
  • [34] Ustekinumab for the treatment of Crohn's disease
    Hansen, Tawnya
    Targownik, Laura E.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (09) : 989 - 994
  • [35] Laparoscopic Treatment of Crohn’s Disease
    Alessandro Fichera
    World Journal of Surgery, 2011, 35 : 1500 - 1504
  • [36] Ustekinumab for the treatment of Crohn's disease
    Khanna, Reena
    Feagan, Brian G.
    IMMUNOTHERAPY, 2013, 5 (08) : 803 - 815
  • [37] Laparoscopic Treatment of Crohn's Disease
    Fichera, Alessandro
    WORLD JOURNAL OF SURGERY, 2011, 35 (07) : 1500 - 1504
  • [38] Treatment of Crohn's disease with infliximab
    Garnett, WR
    Yunker, N
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (04) : 307 - 316
  • [39] Cannabis for the treatment of Crohn's disease
    Kafil, Tahir S.
    Nguyen, Tran M.
    MacDonald, John K.
    Chande, Nilesh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (11):
  • [40] Treatment Algorithms for Crohn's Disease
    Sulz, Michael Christian
    Burri, Emanuel
    Michetti, Pierre
    Rogler, Gerhard
    Peyrin-Biroulet, Laurent
    Seibold, Frank
    DIGESTION, 2020, 101 (SUPPL 1) : 43 - 57
12345